Agilon Health shares are trading lower. Yesterday, B of A Securities downgraded the stock from Buy to Underperform and announced a $3 price target.
Portfolio Pulse from Benzinga Newsdesk
Agilon Health shares are experiencing a decline following a downgrade by B of A Securities from Buy to Underperform, with a new price target set at $3.
October 03, 2024 | 4:57 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Agilon Health's stock is under pressure after B of A Securities downgraded it from Buy to Underperform, setting a $3 price target.
The downgrade from a reputable financial institution like B of A Securities is likely to negatively impact investor sentiment and lead to a decrease in Agilon Health's stock price. The new price target of $3 suggests a significant downside from current levels.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100